2013 Top20 Ranking of Global Pharmaceutical Research and Development Expenditure
-
Last Update: 2020-06-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Business Agency, March 20 (Upi) -- Reports of drug companies cutting research and development spending have been on the rise over the past yearHowever, according to GEN's recently released Top20 Ranking of Global Pharmaceutical Companies' Research and Development Expenditures 2013, more pharmaceutical companies (12) actually increased their spending on research and development in 2013, while eight pharmaceutical companies actually increased their spending on research and developmentthe reasons for fluctuations in research and development spending varyBut the increase in research and development spending has inevitably underscored the need to strongly support late-stage clinical projects, while drug companies, which have reduced research and development spending, tend to cut spending as part of a company-wide restructuring to reduce costs and improve efficiencydata show that most pharmaceutical giants cut back on research and development spending in 2013, while biotech companies continued to increase research and development spending, but overall the level was still below the pharmaceutical giant'sThe detailed list data is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
